Automotive Collision Repair Market Revenue will be $202.24 Billion By 2024: Grand View Research, Inc.

The global automotive collision repair market is expected to reach USD 202.24 billion by 2024, according to a new study by Grand View Research, Inc. Advancements in claims, insurance, and the automobile aftermarket have led to the development of new repair techniques and modern processes, which have significantly widened the scope across the passenger and commercial vehicle categories. The untapped and unorganized automotive collision repair market in the Asia Pacific region is positioned as a major opportunity for the key vehicle repair vendors.

Advanced 3D production capabilities are being utilized by numerous leading manufacturers including Daimler AG (Germany) and BMW Group (Germany) in the production of spare parts and associated automobile components. For instance, Rolls-Royce Dawn 2016 is expected to use the 3D printing technology for fabricating mounting brackets for wire hoses and fiber-optic cables. Moreover, organizations such as the U.S. National Automotive Service Task Force (NASTF) have established a Collision Repair Committee (CRC) that helps recognize, address, and resolve the repair/service gaps in order to help vehicle repair centers accomplish a complete and safe automotive restoration for vehicle owners. 

Request for Sample Copy of this report:

http://www.grandviewresearch.com/industry-analysis/automotive-collision-repair-market

Further key findings from the study suggest:

• Paints, clear coatings, and accompanying consumables such as auto components and other spares are widely used in the automotive collision repair market. Coatings and paints are utilized to cover up dents and scratches in case of automotive body damages. The growing penetration of gas and hybrid electric cars is expected to further drive the industry with a new generation of vehicles coming in the demanding novel service repair regimens. This trend would help in laying the foundation of specialized auto collision repair shops catering to specific makes of vehicles.
• Transport authorities and administrations across different countries have made it obligatory for car owners to buy insurance coverage in case of any damage to the insured vehicle and the driver. The increasing number of automobiles on the road in Asia Pacific countries, such as India and Japan, is expected to drive the regional automotive collision repair market.
• The key players in the automotive collision repair market include Continental Corporation, DuPont, Federal-Mogul Holdings, Bosch, DENSO Corporation, and 3M. The industry observes frequent mergers and acquisitions in order to expand their share and global reach in the market.
• The industry is expected to remain innovation-led with the introduction of new metals and chemicals that provide cost efficiency and weight reduction in automobiles. The increasing demand for automobiles is projected to trigger the demand for automobile collision repair centers. Stringent standards across the globe for car safety are anticipated to drive the collision repair industry.

To See More Reports of Automotive Industry: 

http://www.grandviewresearch.com/industry/automotive-and-transportation

Grand View Research has segmented the global automotive collision repair market on the basis of product, vehicle type, and region:

Automotive Collision Repair Product Outlook (Revenue, USD Billion; 2014 - 2024)

• Paints & Coatings
• Consumables
• Spare Parts

Automotive Collision Repair Vehicle Type Outlook (Revenue, USD Billion; 2014 - 2024)

• Light-duty Vehicles
• Heavy-duty Vehicles

Automotive Collision Repair Regional Outlook (Revenue, USD Billion; 2014 - 2024)

• North America
• Europe
• Asia Pacific
• South America
• Middle East & Africa 

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Automotive Air Filters Market is to be $8.62 Billion By 2024: Grand View Research, Inc.

The global automotive air filters market is expected to reach USD 8.62 billion by 2024, according to a new report by Grand View Research, Inc. Rising disposable income coupled with the growth of global automobile industry and stringent emission norms is expected to drive the market growth over the next eight years.

The global automotive air filters market is estimated to witness a high growth owing to rising automobile production along with rapid industrialization and urbanization. Stringent emission control regulations are expected to foster the market growth.

Growing disposable income in developing regions such as Asia Pacific and the Middle East is presumed to drive the growth. Economies such as India and China are projected to have brisk growth and lead their regional market. Volatile raw materials cost is presumed to hamper the industry growth. The increase in electric vehicles production is also estimated to hinder the market growth shortly.

Favorable regulation such as EU and EEA member states emission standards which include Euro VI petrol and diesel norms. This norm is to govern light and commercial passenger vehicles emissions and is anticipated to have a positive impact on automotive air filters demand in engine components.

For More Details of this Report: http://www.grandviewresearch.com/industry-analysis/automotive-air-filters-market

Further key findings from the report suggest:

• Cabin filter emerged as the leading product segment and accounted for 51.6% of total market revenue in 2015. Cabin filters are estimated to grow at a rapid pace at an estimated CAGR of a 9.1% from 2016 to 2024. The growth can be attributed due to favorable emission control regulation and consumer concern towards safe car environment.
• Passenger car application segment dominated the automotive air filters demand and accounted for over 50% of the total market in 2015. Increasing demand in automobile industry coupled with rapid automobile production is expected to benefit the overall filters demand in automotive.
• In 2015, Aftermarket segment in end-use had the highest penetration in the automotive air filters market with over 70% of the total market. This trend is expected to continue over the next eight years. Rising disposable income across emerging nations is estimated to favor the market growth.
• Asia Pacific had the highest regional market penetration in 2015 and accounted for over 45% of global demand. Increasing automobile production in India, China, Thailand and Indonesia is expected to drive the regional market over the forecast period.
• Key market participants include Ac Delco Inc., Affinia Group Inc., Denso Corporation, Hollingsworth & Vose Co. Inc., Mann+Hummel, Roki Co. Ltd, Donaldson Company Inc., K&N Engineering Inc., Robert Bosch GmbH, Ahlstrom Corporation, SogefiS.p.A, Neenah Paper Inc., Clarcor Inc., Parker Hannifin Corp., Freudenberg & Co. Kg, Lydall Inc., Toyota Boshoku Corporation, Cummins Inc., Hengst GMBH & Co. Kg, Mahle GmbH and Valeo S.A.

Read Our Blog: http://www.grandviewresearch.com/blogs/advanced-materials

Grand View Research has segmented the global automotive Air filters market on the basis of product, application, end-use and region:

Global Automotive Air Filters Application Outlook (USD Million, 2014 - 2024)

• Passenger car
• Light and heavy commercial vehicle
• Two wheelers

Global Automotive Air Filters Product Outlook (USD Million, 2014 - 2024)

• Intake
• Cabin

Global Automotive Air Filters End-Use Outlook (USD Million, 2014 - 2024)

• OEM
• Aftermarket

Global Automotive Air Filters Regional Outlook (USD Million, 2014 - 2024)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • Germany
  • France
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
• Middle East & Africa
• Central & South America

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Phototherapy Equipment Market is going to exceed $788.7 Million By 2025: Grand View Research, Inc.

The global phototherapy equipment market is expected to reach a value of USD 788.7 million by 2025, according to a new report by Grand View Research, Inc. Rising prevalence of skin diseases has led to huge growth of phototherapy equipment market. According to healthline data, nearly 150,000 new psoriasis cases develop each year among the U.S. population. With such huge population developing psoriasis, there is a growing need for phototherapy devices in the near future. Eczema, one of the severe skin diseases also has contributed towards the growth of the market.

Neonatal jaundice is another disease that require phototherapy treatment. This kind of treatment is very common among newborns suffering from jaundice in order to reduce high bilirubin levels. According to National Center for Biotechnology Information (NCBI), around 60% to 80% of healthy newborns are likely to develop neonatal jaundice. Hence, demand for phototherapy equipment is expected to rise with growing prevalence of neonatal jaundice.

Furthermore, technological advancements are continuously rising pertaining to this market. LED-based devices are being highly adopted, which has further accelerated the growth of the market. The LED lights are cheaper as compared to conventional phototherapy equipment and has a long-lasting effect. These lights also have been proved to be very effective for treating neonatal jaundice. Hence, improvement in technology has impacted the growth of the market.

Access Research Report On Phototherapy Equipment Market Analysis:http://www.grandviewresearch.com/industry-analysis/phototherapy-equipment-market

Further key findings from the study suggest:

• In 2016, amongst the product segment, conventional phototherapy equipment held the largest market share due to its wide usage for skin disease treatment
• LED equipment are expected to show attractive growth over the forecast period due to its cost-effectiveness and long-lasting effect
• Amongst the application segment, skin disease treatment accounted for the largest revenue share in 2016 owing to rising prevalence of psoriasis and eczema
• Neonatal jaundice management is anticipated to witness significant growth over the forecast period due to increasing incidence of newborn jaundice
• North America dominated the market in 2016 owing to penetration of advanced technology in the field of phototherapy treatment in this region
• Some of the key players are GE Healthcare; Philips Lighting Holding B.V.; Nice Neotech Medical Systems Pvt. Ltd.; Natus Medical Incorporated; Phoenix Medical Systems Pvt. Ltd.; and Herbert Waldmann GmbH & Co. KG.

Read our Blog: http://www.grandviewresearch.com/blog/phototherapy-equipment-market-size-share

Grand View Research has segmented the phototherapy equipment/Instrument market on the basis of product, application, end-use and region:

Phototherapy Equipment Product Outlook (Revenue, USD Million; 2014 - 2025)

• Conventional Phototherapy Equipment               
  • Conventional Phototherapy Equipment with Fluorescent Lamp 
  • Conventional Phototherapy Equipment with Compact Fluorescent Lamp         
• LED Phototherapy Equipment                 
• Fiberoptic Phototherapy Equipment

Phototherapy Equipment Application Outlook (Revenue, USD Million; 2014-2025)

• Skin Disease Treatment  
  • Psoriasis
  • Vitiligo
  • Eczema
  • Others
• Neonatal Jaundice Management

Phototherapy Equipment End-Use Outlook (Revenue, USD Million; 2014 - 2025)

• Hospitals & Clinics        
• Homecare

Phototherapy Equipment Regional Outlook (Revenue, USD Million; 2014 - 2025)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK
• Asia Pacific
  • Japan
  • China
  • India
• Latin America
  • Brazil
  • Mexico
• MEA
  • South Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Non-small Cell Lung Cancer Therapeutics Market Is Expected To Reach $12.2 Billion By 2025: Grand View research, Inc.

The global non-small cell lung cancer therapeutics market is expected to reach a value of USD 12.2 billion by 2025, based on a new report by Grand View Research, Inc. The non-small cell cancer therapeutics (NSCLC) market is anticipated to witness significant growth during the forecast period. This can be attributed to the high investment by market players in the research and development of lung cancer therapy, presence of a rich pipeline, and increasing penetration of drugs during the forecast period.

Introduction of several drugs in various geographical regions is likely to drive the market during the forecast period. For instance, in October 2016, the FDA granted Breakthrough Therapy Designation to Alecensa (alectinib), a drug developed by Genentech to treat ALK-positive NSCLC as a first-line treatment. The drug has been approved in the U.S., Japan, Canada, Hong Kong, South Korea, Kuwait, and Israel.

Presence of a strong pipeline of drugs for non-small cell lung cancer helps propel the market during the forecast period. Bristol-Myers Squibb Company, Orion Corporation, Merck KGaA, AstraZeneca, F. Hoffmann-La Roche Ltd, and Pfizer, Inc. have major molecules in the pipeline.

Access research report on Non-small Cell Lung Cancer Therapeutics Market analysis: http://www.grandviewresearch.com/industry-analysis/non-small-cell-lung-cancer-nsclc-therapeutics-market

Further key findings from the study suggest:

• By drug, Alimta accounted for the highest share in 2015. However, it is expected to witness decline in its share during the forecast period.
• Alecensa (alectinib) is expected to grow at the highest rate during the forecast period. This is majorly attributed to the clinical benefit of the drug to treat ALK-positive NSCLC.
• Alecensa is expected to be a competitor to Pfizer’s Xalkori and Merck’s Keytruda during the forecast period. A superior progression-free survival rate of Alecensa was observed in the clinical trials as compared to Crizotinib.
• Geographically, North America dominated the overall industry in 2015. This is due to the early entry of drugs in the market, increased adoption of new treatment, and high cost of the drug.
• It is expected that North America would maintain its dominance during the forecast period and grow with the highest rate over the coming years due to expected entry of new drugs.
• Several players are operating in the industry. Geographical penetration and development of innovative & effective drugs are the key strategies of the players to increase their share.
• Some of the key players are GlaxoSmithKline (GSK) Plc., Novartis AG, AstraZeneca, F. Hoffmann-La Roche AG, Bristol-Myers Squibb, Pfizer Inc., Eli Lilly & Company, and Sanofi.

Read Our Blog: http://www.grandviewresearch.com/blog/non-small-cell-lung-cancer-nsclc-market-size-share

Grand View Research has segmented the non-small cell lung cancer therapeutics market by drug and region:

Non-small Cell Lung Cancer Therapeutics Market Drug Outlook (Market Revenue in USD Million, 2014 - 2025)

• Alimta
• Iressa
• Avastin
• Tarceva
• Zykadia
• Tagrisso
• Xalkori
• Cyramza
• Opdivo
• Alecensa

Non-small Cell Lung Cancer Therapeutics Market Regional Outlook (Market Revenue in USD Million, 2014 - 2025)

• North America
  • US.
  • Canada
• Europe
  • UK
  • Germany
• Asia Pacific
  • Japan
  • China
• Latin America
  • Brazil
  • Mexico
• Middle East and Africa
  • South Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Medical Foods Market is projected to beat $24.4 Billion By 2025: Grand View Research, Inc.

The global medical foods market is expected to reach a value of USD 24.4 billion by 2025, according to a new report by Grand View Research, Inc. The medical foods market is anticipated to grow at a CAGR of 6.9% over the forecast period. The key factors supporting expansion include the growing awareness about medical foods, improvement in patient healthcare outcomes, rise in prevalence of several chronic diseases, increase in malnutrition, and continuous innovation.

The use of medical foods to assist the patients during the treatment of chronic diseases has been a prevalent practice. However, lack of awareness about the proper usage, quality concerns, and overlapping claims about benefits associated due to the usage of medical foods have restricted the growth of medical foods market.

The difference between functional foods, dietary supplements, and medical foods is still not clear for several healthcare practitioners. Therefore, errors in prescription or use of substitute products is a major trend observed in the market. Furthermore, the regulatory uncertainty pertaining to the classification of medical foods as a separate category has also affected the market growth.

The prevalence of chronic diseases such as diabetic neuropathy, Alzheimer’s, Attention Deficit Hyperactivity Disorder (ADHD), and several metabolic diseases is increasing rapidly The risk of neuropathy significantly increases with increase in age, changes in diet, and adoption of an unhealthy lifestyle. Some of the symptoms usually associated with neuropathy include numbness, tingling, and pain in the feet, arms, & legs. Furthermore, some of the key products used to treat this condition include Percura capsules, METANX, and Foltanx.

The growing number of patients with Alzheimer’s disease is also increasing rapidly. As per the estimates published by the Alzheimer’s Society, in the U.S., an estimated 5.4 million Americans across all ages are suffering from this disease. On further analysis of the data, it is observed that nearly 5.2 million people are aged 65 and above. Thus, rise in the geriatric population is also a major factor driving the medical foods market.

Access research report on medical foods market analysis:
http://www.grandviewresearch.com/industry-analysis/medical-foods-market

Further Key Findings from the Study Suggest:

• In 2015, oral route held the highest share as majority of the products are administered through the oral feeding
• In 2015, powders category accounted for nearly 79% of the market share
• In 2015, diabetic neuropathy was the largest application with a share of 34.3% owing to growing awareness about nutritional requirements during the treatment of chronic diseases
• Asia Pacific is expected to lead the growth with a CAGR of 7.8% from 2016 to 2025
• Some of the key players are Danone; Nestlé; Abbott; Targeted Medical Pharma Inc.; Primus Pharmaceuticals Inc.; Mead Johnson & Company, LLC.; and Fresenius Kabi AG.

Read Our Blog: http://www.grandviewresearch.com/blog/medical-foods-market-size-share

Grand View Research has segmented the medical foods market by route of administration, by product, by application, and by region:

Medical Foods Route of Administration Outlook (Revenue in USD Million, 2014 - 2025)

• Oral
• Enteral

Medical Foods Product Outlook (Revenue in USD Million, 2014 - 2025)

• Pills
• Powder
• Others

Medical Foods Application Outlook (Revenue in USD Million, 2014 - 2025)

• Diabetic Neuropathy
• ADHD
• Depression
• Alzheimer’s disease
• Nutritional Deficiency
• Others

Medical Foods Regional Outlook (Revenue in USD Million, 2014 - 2025)

• North America
  • US.
  • Canada
• Europe
  • UK
  • Germany
• Asia Pacific
  • Japan
  • China
• Latin America
  • Brazil
  • Mexico
• Middle East and Africa
  • South Africa

 About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Transcatheter Pulmonary Valve Market Revenue will reach $54.1 Million By 2025: Grand View Research, Inc.

The global transcatheter pulmonary valve market is expected to reach a value of USD 54.1 million by 2025, according to a new report by Grand View Research, Inc. The technological advancements pertaining to heart valve technologies, and increasing number of clinical trials pipeline by various public and private players are some of the crucial factors expected to boost the market over the forecast period.

In 2015, North America held the majority of market share of nearly 80.6% in the global market. Some of the major drivers are increasing prevalence of the various cardiovascular disorders, growing geriatric population with heart valve diseases such as pulmonary stenosis, pulmonary regurgitation, and others, and rising awareness regarding the benefits of transcatheter valves over surgical procedures. The growing number of patients suffering from long-term heart disorders, rising awareness about technologically advanced heart valve, and increasing healthcare expenditures and reimbursement policies for overall transcatheter valves are some of the key contributors to the growth of the market globally.

However, Asia Pacific is expected to show a growth in this market after 2019, as there will be several product launch in this region. The Asia Pacific region is expected to grow at a lucrative growth rate owing to the growth of many developing economies like Japan and China. These developing countries show a potential of growth due to various contributors such as the increasing aging population and growing prevalence of heart diseases. Moreover, the presence of a large pool of patients, developing healthcare infrastructure & services, increasing disposable income, and rising government funding are some of the factors that are expected to drive the market during the forecast period.

Request for sample copy of this report: http://www.grandviewresearch.com/industry-analysis/transcatheter-pulmonary-valve-market

Further key findings from the study suggest:

• In 2015, tetralogy of Fallot (ToF) was the largest application segment, owing to the growing prevalence of ToF and the presence of huge product portfolio
• In 2015, balloon transcatheter valve segment held majority of the revenue share and is expected to be the fastest growing market during the forecast period
• The presence of huge patient base and growing interest among the private and public players to launch product after the completion of clinical trial in 2017 is expected to drive the Asia Pacific market
• Some of the key players are Boston Scientific Corporation, Braile Biomédica, Direct Flow Medical, Edwards Lifesciences Corporation, JenaValve Technology, Inc., St. Jude Medical, SYMETIS, Colibri Heart Valve, LLC, VENUS MEDTECH, and XELTIS.

Read Our Blog: http://www.grandviewresearch.com/blog/transcatheter-pulmonary-valve-market-size-share

Grand View Research has segmented the transcatheter pulmonary valve market by application, technology, end-use, raw material, and region:

Transcatheter Pulmonary Valve Application Outlook (Revenue in USD Million, 2014 - 2025)

• Cardiac Anomaly
• Pulmonary Atresia
• Pulmonary Stenosis
• Pulmonary Regurgitation
• Tetralogy of Fallot
• Truncus Arteriosus
• Others

Transcatheter Pulmonary Valve Technology Outlook (Revenue in USD Million, 2014 - 2025)

• Balloon-Expanded Transcatheter Valve
• Self-Expanded Transcatheter Valve

Transcatheter Pulmonary Valve End-Use Outlook (Revenue in USD Million, 2014 - 2025)

• Adult
• Pediatric

Transcatheter Pulmonary Valve Raw Material Outlook (Revenue in USD Million, 2014 - 2025)

• Synthetic Transcatheter Valve
• Tissue Engineered Transcatheter Valve

Transcatheter Pulmonary Valve Regional Outlook (Revenue in USD Million, 2014 - 2025)

• North America
  • US.
  • Canada
• Europe
  • UK
  • Germany
  • Spain
  • Russia
  • France
  • Italy
• Asia Pacific
  • China
  • Japan
  • Hong Kong
  • Taiwan
• Latin America
  • Mexico
  • Brazil
• MEA
  • South Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Transparent Ceramics market is likely to witness growth at a CAGR of 21.8% from 2016 to 2024

The global transparent ceramics market is expected to reach USD 1.08 billion by 2024, according to a new report by Grand View Research, Inc. Increasing demand for the product in various industries including electronics, aviation, and healthcare as a substitute for existing glass technologies in numerous function such as armors, optical fibers, domes(infrared) & lasers is expected to drive demand. Expansion of these end-use industries is predicted to fuel the industry growth further over the next eight years.

Rising focus on utilizing cutting & laser tools across the world, on account of rapid industrialization and turnaround of the manufacturing sector, is expected to propel growth. The increase of the ceramics industry is also driving expansion over the next eight years.

The global market for transparent ceramics was valued at USD 178.5 million in 2015 and is expected to witness growth over the forecast period on account of rising manufacturing facilities in emerging markets of Asia Pacific such as India and China coupled with increasing expenditure on defense on improved & enhanced technology. Growing need from end-user industries such as chemical & mechanical industries, instrumentation & sensor and optics & optoelectronics is expected to stimulate expansion. 

Access research report on Transparent Ceramics Market analysis: http://www.grandviewresearch.com/industry-analysis/transparent-ceramics-market

Further key findings from the report suggest:

• Transparent ceramics blankets are suitable for high-temperature procedures. Lightweight, low thermal conductivity & heat storage, soaring temperature stability, outstanding handling power & fire protection, corrosion and thermal shock resistance and resistance are some of the properties owing to which blankets are preferred. The market is likely to witness growth at a CAGR of 21.8% from 2016 to 2024.
• The transparent ceramics demand in optic & optoelectronics was USD 61.4 million in 2015. These products are used in medical & healthcare industries. Advancements in the healthcare sector across the globe is expected to drive industry development over the forecast period.
• Asia Pacific contributed to 47.1% of the global market in 2015 and is projected to witness massive expansion in light of augmented government expenditure on the industrial sector and increasing opportunities for FDI in China and India. Rising demand for defense and iron & steel on account of rapid industrialization is expected to drive growth.
• The Middle East & Africa is expected to observe considerable gains at a CAGR of 20.9% from 2016 to 2024. Increasing expenditure on aviation & defense by governments in the Middle East is expected to propel growth.
• Key industry players include Surmet Corporation, CoorsTek, Murata Manufacturing Co. Ltd., ETEC, and Koito Manufacturing. These companies focus on research for product development to enhance their portfolio. Also, numerous research institutes are also focusing on R&D for increasing the application scope of transparent ceramics. For instance, in April 2014, the U.S. Naval Research Laboratory (NRL) developed a method that fabricates nanocrystalline spinel, which is 50% harder than the existing spinel armor materials utilized in military vehicles.

Read Our Blog: http://www.grandviewresearch.com/blogs/advanced-materials

Grand View Research has segmented the global transparent ceramics market on the basis of product, material, application and region:

Product Outlook (Revenue, USD Million; 2016 - 2024)

• Sapphire
• Yttrium Aluminum Garnet
• Aluminum Oxynitride
• Spinel
• Others

Material Outlook (Revenue, USD Million; 2016 - 2024)

• Monocrystalline Transparent Ceramics
• Polycrystalline Transparent Ceramics
• Others

Application Outlook (Revenue, USD Million; 2016- 2024)

• Optics & Optoelectronics
• Aerospace, Defense & Security
• Mechanical/Chemical
• Sensors & Instrumentation
• Healthcare
• Consumer
• Energy
• Others

Regional Outlook (Revenue, USD Million; 2016 - 2024)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • Germany
  • France
  • Italy
• Asia Pacific
  • China
  • India
  • Japan
• Latin America
  • Brazil
  • Chile
• MEA

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Transfection Reagent & Equipment Market Is Majorly Driven By Growing Clinical Development Of Biopharmaceuticals Sector Till 2022: Grand View Research

Grand View Research, Inc. - Market Research And Consulting. Global transfection reagent and equipment market size was valued at USD 616.59 million in 2014.

The global transfection reagent & equipment market is expected to reach USD 1,086.02 million by 2022, according to a new report by Grand View Research, Inc. This anticipated growth in demand can be attributed to growing need for protein production, biopharmaceutical development, and vaccine research and development; all of which rely heavily on cytological R&D and transfection.

Larger market entities are also involved in efforts to expand their market presence in the Asia Pacific region and tap the high potential for growth available. Expected growth of genomic and proteomic research is also a strong factor which will positively impact the growth in demand for transfection. 

Access research report on Transfection Reagent & Equipment Market analysis:http://www.grandviewresearch.com/industry-analysis/transfection-reagents-and-equipment-market

Further key findings from the study suggest:

• Out of both the broad segments of products available, transfection equipment accounted for a larger share of the market in 2014 and owing to their inherently more expensive nature than reagents are expected to maintain this dominant position over the forecast period.
• The market space for transfection has an abundant number of methods to achieve the aforementioned. However, these vary significantly in usage rates and implementation complexities. Electroporation and liposomal transfection combine to account for over 30% of the market owing to high associated advantages.
• Growing applications of transfection techniques poise the segments in a strong position and estimated valuation clocks usage of transfection in gene expression at over USD 130 million and for protein production at over USD 110 million for the year 2014.
• North America was observed to be responsible for the largest share of revenue in 2014 which amounted to a little over USD 240 million. The United States houses the headquarters of operations for a number of market leaders and a number of established research and development. This provides a strong platform for development, manufacture & distribution various vaccines, and biopharmaceuticals which fuels market growth.
• However, it is Asia Pacific region which is anticipated to witness significant growth over the forecast period in various segments owing to considerable growth of cytological research, development of biosimilar drugs and high potential of growth in these relatively untapped regional segments.
• Asia Pacific is expected to grow at a significant rate over the forecast period in terms of increasing production and development of vaccines, drugs, and new biologics. Supportive government initiatives pertaining to increasing investments by manufacturers and governments in biopharmaceutical manufacturing and high untapped market opportunities are the important factors accounting for the expected growth of market in this region over the forecast period.
• Promega, Roche and Thermo Fisher owned Life Technologies accounted for the largest of revenue in 2014 and are involved in new product development for expansion of their portfolios over the forecast period. Acquisition of smaller players is also expected over the forecast period by larger companies
• Key market players in the Transfection Reagent & Equipment Market include BTX (Harvards Apparatus Inc.), SignaGen Laboratories, OriGene Technologies, EMD Millipore, VWR International LLC, Bio-Rad Laboratories Inc., Mirus Bio LLC, F. Hoffman-La Roche AG, Lonza AG, Life Technologies (Thermo Fisher), and Promega Corporation.

Read Our Blog: http://www.grandviewresearch.com/blogs/healthcare

Grand View Research has segmented Transfection Reagent & Equipment Market on the basis of product, method, application, and region:

Global Transfection reagents & equipment Product Outlook (Revenue, USD Million, 2012 - 2022)

• Reagents
• Equipment

Global Transfection reagents & equipment Method Outlook (Revenue, USD Million, 2012 - 2022)

• Electroporation
• Liposomes
• Particle Bombardment
• Microinjection
• Adenoviral vectors
• Direct microinjection
• Calcium phosphate
• DEAE-dextran
• Magnetic beads
• Activated Dendrimers
• Laserfection

Global Transfection reagents & equipment Application Outlook (Revenue, USD Million, 2012 - 2022)

• Gene expression studies
• Protein production
• Transgenic delivery
• Cancer research
• Biomedical research

Transfection reagents & equipment Regional Outlook (Revenue, USD Million, 2012 - 2022)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK
• Asia Pacific
  • Japan
  • China
• Latin America
  • Brazil
• MEA
  • South Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Critical Care Medicine and Organ Transplantation is likely to driving the growth of the Therapeutic Drug Monitoring Market Till 2024

The global therapeutic drug monitoring market is expected to reach over USD 3.37 billion by 2024, according to a new report by Grand View Research, Inc. Recent technological advancements in the Point-of-Care (PoC) devices hold considerable transformative promises for the personalized predictive and preventive medicine. Therapeutic Drug Monitoring (TDM) forms a foundational part to the devising of personalized treatment plans for patients; and the advent of PoC diagnostic devices that yield quantitative measurements of the drug concentration plays a pivotal role in supporting the development of the precision medicine field in the healthcare sector. However, the broad application of the PoC devices for patient monitoring is still lagging behind. The presence of this untapped opportunity is one of the high impact rendering drivers for the market growth.

The employment of continuous therapeutic drug and metabolite monitoring in the early phase of the medication regimen, administered post-organ transplantation, forms a major application in the areas of critical care medicine and organ transplantation, which is expected to propel the growth of the therapeutic drug monitoring market over the forecast period. In addition, the imposing burden of diseases, such as epilepsy and cancer, the rising government initiatives, and the presence of high-unmet needs are some of the crucial determinants expected to further favor the emergence of this market.

Access Research Report On Therapeutic Drug Monitoring Analysis:http://www.grandviewresearch.com/industry-analysis/therapeutic-drug-monitoring-market

Further key findings from the study suggest:

• The consumables segment covered over 65% of the market share in 2015 as a consequence of the extensive requirement of the consumables in the research laboratories and due to the repeat purchase of the kits and reagents.
• The immunoassay segment held the largest market share in 2015. The presence of several commercially available immunoassays combined with their associated benefits including the cost effectiveness and easy-to-handle nature of the products are the key drivers for the growth of this segment.
• The proteomics category is expected to be the fastest growing technology segment due to the advent of various proteomic technologies, such as isotope-coded affinity tags, next generation sequencing, and protein microarray platforms that enable rapid mining of the proteome.
• The hospital is the largest end-use segment with a share of over 60% in 2015. In larger hospitals, various underlying technologies are employed to perform immunoassays; these comprise chemiluminescence, nephelometry, colorimetry, and fluorescence, which are available for the testing of a wide ranging drug panel.
• The drug monitoring for the immunosuppressants is one of the fastest growing application segments owing to the introduction of novel TDM point-of-care testing devices for the evaluation of the concentration of administered immunosuppressants and the complementary metabolites, in order to achieve a prominent therapeutic effect while preventing drug toxicity events in patients that have undergone transplantations.
• In 2015, North America was the highest revenue generating region with revenue generated over USD 900 million. The rising number of R&D activities coupled with the high awareness about personalized therapy is the major determining factor for the large share captured by the North America region.
• Few of the leading market players are Roche Diagnostics, Siemens Healthcare GmbH, Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Beckman Coulter, Inc., Abbott Laboratories, Inc., Agilent Technologies, Inc., bioMérieux, Inc., and Alere, Inc. The persistent R&D efforts are being undertaken along with numerous other strategic endeavors being adopted by the market players with the objective of enhancing the present drug monitoring practices and to develop novel technologies.

Read Our Blog: http://www.grandviewresearch.com/blogs/healthcare

Grand View Research has segmented the therapeutic drug monitoring market on the basis of product, technology, application, end-use, and region:

Therapeutic Drug Monitoring Market, Product Outlook, by Revenue (USD Million, 2013 - 2024)

• Consumables
• Equipment
• Others

Therapeutic Drug Monitoring Market, Technology Outlook, by Revenue (USD Million, 2013 - 2024)

• Immunoassays
• Proteomic technologies
• Others

Therapeutic Drug Monitoring Market Drug, Class Outlook, by Revenue (USD Million, 2013 - 2024)

• Anti-epileptics
• Antibiotics
• Immunosuppressants
• Psychoactive drugs
• Antiarrhythmic drugs
• Others

Therapeutic Drug Monitoring Market, End-use Outlook, by Revenue (USD Million, 2013 - 2024)

• Hospital labs
• Private labs
• Others

Therapeutic Drug Monitoring Market, Regional Outlook, by Revenue (USD Million, 2013 - 2024)

• North America
  • US.
  • Canada
• Europe
  • UK
  • Germany
• Asia Pacific
  • Japan
  • China
• Latin America
  • Brazil
• MEA
  • South Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Biologics Market Size to be $399.5 Billion By 2025: Grand View Research, Inc.

The global biologics market is anticipated to reach USD 399.5 billion by 2025, according to a new report by Grand View Research, Inc. Introduction of targeted therapies coupled with rising adoption of patient centric personalized medicine anticipated to fuel demand. Ever-increasing understanding of the cell physiology and stress, as well as the factors involved in protein production and heterologous gene expression have empowered the use of different living factories.

These living factories are the prokaryotic and eukaryotic cells. Enhancement of drug functionality through achieving successful protein folding and post-translational modifications is supportive for projected progress rate.

Moreover, rising adoption of biopharmaceuticals over chemically synthesized molecules is expected to propel revenue generation significantly. In addition to this, presence of several metabolic disorders that can be treated through the use of biologics is attributive to influence demand.

Combination of advanced bioengineering technologies for biopharmaceutical production is expected to boost progress in pharmaceutical industry. With recent advances in automation, the selection process can be done through high throughput screening (HTS) system for selection of viable clones.

Aforementioned method enables robust production of biopharmaceutical products by obtaining high-producing cell line. Advances with respect to upstream and downstream processing would directly translate into the growth in revenue for this market at a larger level.

However, development of biosimilars is expected to restrain the biologics year on year growth to certain extent. Although, the regulatory approval pathway for these products is not framed yet some drug manufacturers are opting to invest in the development of biobetters.

Access research report on biologics market analysis:http://www.grandviewresearch.com/industry-analysis/biologics-market

Further key findings from the report suggest:

• Microbial expression systems dominated the market with respect to biopharmaceutical manufacturing
• Presence of substantial number of products manufactured through the use of microbial sources can be attributed for largest share
• Higher usage of monoclonal antibodies for the treatment of different diseases responsible for revenue generation
• Moreover, pipeline drugs in the phase of development anticipated to bolster growth
• Significant development pertaining to vaccines and increasing adoption anticipated to fuel progress
• Oncology dominated over a decade and is expected to sustain its share over the forecast period.
• Introduction of novel biologics with high efficacy coupled with the augmenting incidences of cancer is the vital impact rendering factor.
• Substantial sales of biologics in the U.S. can be attributed for the largest share of North American market.
• Established participants are implementing the manufacture of complex moieties in-house, which pronounces for the larger share of in-house manufacturing.
• Asia Pacific is projected to showcase fastest growth in the coming years.
• Increasing penetration of the biologics in the developing economies is expected to contribute in the projected growth.
• Moreover, the university based projects implemented herein are attributive for the projected growth.
• Key players contributing in this market are F Hoffman La Roche, Samsung Biologics, Celltrion, Pfizer Inc., Amgen, Novo Nordisk A/S, Sanofi, Abbvie Inc., Merck & Co. Inc, Addgene, Johnson & Johnson Services Inc., and Eli Lilly & Company.
• These participants are investing in the hybrid business models through providing technology and service platforms.
• Such milestones and royalties from partnered programs enables the cash flow generation which can be utilized in proprietary R&D.

Read Our Blog: http://www.grandviewresearch.com/blogs/healthcare

Grand View Research has segmented the biologics market on the basis of source, product, manufacturing, disease category, and region:

Biologics Source Outlook (Revenue, USD Billion, 2014 - 2025)

• Microbial
• Mammalian
• Others

Biologics Product Outlook (Revenue, USD Billion, 2014 - 2025)

• Monoclonal Antibodies
  • By application
    • Diagnostic
      • Biochemical Analysis
      • Diagnostic Imaging
    • Therapeutic
      • Direct MAB Agents
      • Targeting MAB Agents
    • Protein Purification
    • Others
  • By type
    • Murine
    • Chimeric
    • Humanized
    • Human
    • Others
  • Vaccines
  • Recombinant Proteins
  • Antisense, RNAi, & Molecular Therapy
  • Others

Biologics Manufacturing Outlook (Revenue, USD Billion, 2014 - 2025)

• In-house
• Outsourced

Biologics Disease Category Outlook (Revenue, USD Billion, 2014 - 2025)

• Oncology
  • By Product
    • MABs
    • Vaccines
    • Recombinant Proteins
    • Antisense, RNAi, & Molecular Therapy
    • Others (Certain products under trials related to blood products etc)
  • Infectious Diseases
    • By Product
      • Vaccines
      • MABs
      • Antisense, RNAi, & Molecular Therapy
      • Recombinant Proteins
      • Others
    • Immunological Disorders
    • Cardiovascular Disorders
    • Hematological Disorders
    • Others

Biologics Regional Outlook (Revenue, USD Billion, 2014 - 2025)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK
• Asia Pacific
  • Japan
  • China
• Latin America
  • Brazil
• Middle East and Africa (MEA)
  • South Africa

 About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com